MASH (Metabolic (Dysfunction) Associated Steatohepatitis)

搜索文档
Madrigal Pharmaceuticals(MDGL) - 2025 Q2 - Earnings Call Presentation
2025-08-05 20:00
NASDAQ: MDGL © 2025 Madrigal Pharmaceuticals, Inc. All rights reserved. Forward-looking Statements This presentation includes "forward-looking statements" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, that are based on Madrigal's beliefs and assumptions and on information currently available to it but are subject to factors beyond its control. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regar ...